课题基金 / 基金详情

Molecular Pathology of Rat Osteosarcoma and Malignant Fibrous Histiocytoma

Molecular Pathology of Rat Osteosarcoma and Malignant Fibrous Histiocytoma
大鼠骨肉瘤和恶性纤维组织细胞瘤的分子病理学
批准号:
15591596
负责人:
HONOKI Kanya
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

HONOKI Kanya的其他基金

相似基金

相关文献

中文摘要
翻译
1)研究了STI571对大鼠骨肉瘤和MFH细胞系的作用。所有细胞系的细胞生长均受到时间和剂量依赖性的抑制。MFH细胞系的抑制率更高,约为40%,而骨肉瘤细胞系的抑制率约为20%。疗效的差异取决于PDGFRα的表达。2)研究p16^<INK4a>基因在大鼠骨肉瘤、恶性纤维组织细胞瘤及肺腺癌细胞系中的表达及甲基化状态。PCR-SSCP分析显示p16基因在肺腺癌中未表达,而在骨肉瘤和MFHs中的表达与正常成纤维细胞相似。在骨肉瘤中,靠近编码区的区域高度甲基化,而在肺腺癌中,TATA box附近的区域持续甲基化。MFHs和成纤维细胞在这两个区域均低甲基化。3)研究黄吡醇HMR1275对大鼠骨肉瘤、MFH细胞系和肺腺癌细胞系的影响。所有细胞系的细胞生长均受到时间和剂量依赖性的抑制。肺腺癌细胞系的抑制率最高,约为80%,骨肉瘤和MFH细胞系的抑制率约为60%。5-aza - 2'-脱氧胞苷对p16基因的诱导作用增强了HMR1275.4)研究了2-甲氧基雌二醇和组蛋白去乙酰化酶抑制剂对大鼠骨肉瘤和MFH细胞株的作用。2-甲氧基雌二醇和组蛋白去乙酰化酶抑制剂对两种细胞系的细胞生长均有时间和剂量依赖性的抑制作用。目前正在对这些药物的作用机制进行研究,包括缺氧诱导因子、半胱天冬酶等基因的表达。
英文摘要
1)The effect of STI571 was investigated on rat osteosarcoma and MFH cell lines. The cell growth of all cell lines was inhibited in a time- and dose-dependent manner. The inhibition rate were greater for MFH cell lines, about 40%, while about 20% for osteosarcoma cell lines. The difference of effectiveness was depend on PDGFRα expression.2)We investigated the expression and methylation status of p16^<INK4a> gene in rat osteosarcoma and malignant fibrous histiocytoma as well as rat lung adenocarcinoma cell lines. The PCR-SSCP analysis showed no expression of p16 gene in lung adenocarcinoma, while similar expression in ostesarcomas and MFHs as normal fibroblasts. The region close to coding region was hypermethylated in osteosarcoma, in contrast, the region nearby TATA box was consistently methylated in lung adenocarcinoma. MFHs and fibroblasts were hypomethylated in both regions.3)The effect of HMR1275 (flavopiridol) was investigated on rat osteosarcoma, MFH cell lines and lung adenocarcinoma cell lines. The cell growth of all cell lines was inhibited in a time- and dose-dependent manner. The inhibition rate were the greatest for lung adenocarcinoma cell lines, about 80%, while about 60% for osteosarcoma and MFH cell lines. The induction of p16 gene by the treatment of 5-aza 2'-deoxycytidine enhances the effects of HMR1275.4)The effects of 2-methoxyestradiol and histone deacethylase inhibitor were investigated on rat osteosarcoma and MFH cell lines. The cell growth of both cell lines was inhibited in a time- and dose-dependent manner by both 2-methoxyestradiol and histone deacethylase inhibitor. The investigation of the effect mechanisms for these drugs is now on-going including the gene expression such as hypoxia inducible factor, caspase etc.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
Growth inhibition and induction of apoptosis by Flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines.
Flavopiridol 在大鼠肺腺癌、骨肉瘤和恶性纤维组织细胞瘤细胞系中的生长抑制和诱导细胞凋亡。
DOI: --
发表时间: 2004
期刊: Oncology Reports 11
影响因子: --
作者: [Honoki K, Yoshitani K, et al.]
通讯作者: et al.
Growth inhibition of rat osteodsarcoma and malignant fibrous histiocytoma cells by tyrosine kinase inhibitoe STI571.
酪氨酸激酶抑制剂 STI571 对大鼠骨肉瘤和恶性纤维组织细胞瘤细胞的生长抑制。
DOI: --
发表时间: 2003
期刊: In vivo 17
影响因子: --
作者: [Yoshitani, K., Honoki, K., et al.]
通讯作者: et al.
Molecular Genetics in Bone and Soft Tissue Tumors. In ‘New Perspectives in Cancer Research and Therapy' (S.Kuriyama ed.)
骨和软组织肿瘤的分子遗传学。《癌症研究和治疗的新视角》(S.Kuriyama 编辑)
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: [Kanya Honoki, Yoshio Mii]
通讯作者: Yoshio Mii
Growth Inhibition of rat osteosarcoma and malignant fibrous histiocytoma cells by tyrosine kinase inhibitor STI571
酪氨酸激酶抑制剂STI571对大鼠骨肉瘤和恶性纤维组织细胞瘤细胞生长的抑制作用
DOI: --
发表时间: 2003
期刊: IN VIVO 17
影响因子: --
作者: [Kazuhiro Yoshitani, et al.]
通讯作者: et al.
共 10 条
    Isolation of cancer stem cells in bone and soft tissue tumors and novel molecular and cellular targeting therapy
    • 批准号:
      20591765
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2008
    • 负责人:
      HONOKI Kanya
    • 依托单位:
    海外基金